Chemotherapy for pediatric brain tumors

Area of Science:

• Pediatric Oncology
• Neuro-Oncology
• Clinical Pharmacology

Background:

• Chemotherapy represents a significant advancement in treating pediatric brain tumors.
• Its role is evolving, particularly in balancing efficacy with reduced treatment-related toxicities.

Purpose of the Study:

• To review the current applications and impact of chemotherapy in various pediatric brain tumor types.
• To highlight chemotherapy's benefits in improving survival and enabling radiation dose reduction.
• To identify tumor types that are less responsive to chemotherapy.

Main Methods:

• Review of recent clinical studies and advancements in chemotherapy protocols for pediatric brain tumors.
• Analysis of chemotherapy's impact on disease-free survival, tumor size reduction, and radiation therapy necessity.
• Categorization of tumor responses based on histological type and risk stratification.

Main Results:

• Chemotherapy improves disease-free survival in high-risk primitive neuroectodermal tumors/medulloblastoma.
• It enables radiation therapy reduction in standard-risk patients and delays radiation in infants, mitigating neurotoxicity.
• Tumor size reduction is observed in low-grade glioma, optic glioma, and oligodendroglioma, while high-grade glioma and ependymoma exhibit chemoresistance.

Conclusions:

• Chemotherapy is a valuable tool in managing specific pediatric brain tumors, offering survival benefits and reduced toxicity.
• Further participation in controlled studies is crucial to precisely define chemotherapy's role and optimize treatment strategies.
• Identifying chemoresistant tumor types underscores the need for ongoing research and novel therapeutic approaches.